Skip to main content
Clinical Trials/ACTRN12615000163505
ACTRN12615000163505
Completed
Phase 2

To evaluate the reproducibility of respiratory-related tumour motion in lung cancer patients using the MRI guided audiovisual biofeedback (MRI-AV) system

niversity of Sydney0 sites15 target enrollmentStarted: February 19, 2015Last updated:

Overview

Phase
Phase 2
Status
Completed
Enrollment
15

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Stage I\-III lung cancer of any histology to be treated with radical radiotherapy with or without chemotherapy
  • Ability to have radiological scans, no contraindications to having an MRI scan
  • Ability to lie flat for about 1 hour 10 minutes

Exclusion Criteria

  • Metastatic disease
  • Pregnant women or those mentally impaired
  • People highly dependent on medical care
  • People unable to undergo MRI exam

Investigators

Similar Trials